FDA ships Form 483 to gener­ic drug gi­ant Dr. Red­dy’s due to equip­ment is­sues, oth­er ob­ser­va­tions

The FDA has is­sued a Form 483 let­ter to In­di­an gener­ic drug gi­ant Dr. Red­dy’s Lab­o­ra­to­ries, af­ter the agency found po­ten­tial­ly con­t­a­m­i­nat­ed drugs dur­ing an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER